Effect of ADAMTS-13 on cerebrovascular microthrombosis and neuronal injury after experimental subarachnoid hemorrhage

Journal of Thrombosis and Haemostasis

Volumn 12, Issue 4, 2014, Pages 505-514

  Muroi, C ^a,b,c   Fujioka, M ^a,d   Mishima, K ^a   Irie, K ^a   Fujimura, Y ^d   Nakano, T ^a   Fandino, J ^b   Keller, E ^c   Iwasaki, K ^a   Fujiwara, M ^a  

^a FUKUOKA UNIVERSITY   (Japan)

^b Institute of Aging and Brain Sciences Faculty of Pharmaceutical Sciences Fukuoka University ^*  (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

ADAMTS13, mouse; Cerebral vasospasm; Microcirculation; Subarachnoid hemorrhage; Thrombosis

Indexed keywords

6156 AD; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 6; RECOMBINANT ENZYME; RECOMBINANT HUMAN VON WILLEBRAND FACTOR CLEAVING PROTEINASE; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR CLEAVING PROTEINASE; ADAM PROTEIN; ADAMTS13 PROTEIN, HUMAN; RECOMBINANT PROTEIN; VON WILLEBRAND FACTOR;

ADHESIVE REMOVAL TEST; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN RETRIEVAL; APOPTOSIS; ARTICLE; BLEEDING TIME; BLOOD VESSEL PERFORATION; BLOOD VESSEL WALL; BRAIN CORTEX; BRAIN VASOSPASM; CEREBROVASCULAR MICROTHROMBOSIS; CONTROLLED STUDY; DRUG EFFECT; EXPERIMENTAL NEUROLOGIC DISEASE; EXPERIMENTAL SUBARACHNOID HEMORRHAGE; HIPPOCAMPUS; HISTOPATHOLOGY; HUMAN; MALE; MENTAL PERFORMANCE; MICROTHROMBUS; MORTALITY; MOTOR ACTIVITY; MOTOR PERFORMANCE; MOUSE; NERVE CELL DEGENERATION; NERVE CELL LESION; NERVOUS SYSTEM INFLAMMATION; NEUROLOGIC EXAMINATION; NONHUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; PARIETAL CORTEX; PRIORITY JOURNAL; REFLEX; SUBARACHNOID HEMORRHAGE; TEMPORAL CORTEX; ANIMAL; BLEEDING; BLOOD; C57BL MOUSE; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; INFLAMMATION; INTRACRANIAL THROMBOSIS; METABOLISM; NERVE CELL; PATHOLOGY; TIME;

ADAM PROTEINS; ANIMALS; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEMORRHAGE; HUMANS; INFLAMMATION; INTRACRANIAL THROMBOSIS; MALE; MICE; MICE, INBRED C57BL; NEURONS; RECOMBINANT PROTEINS; SUBARACHNOID HEMORRHAGE; TIME FACTORS; VON WILLEBRAND FACTOR;

EID: 84898032551     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.12511     Document Type: Article

References (28)

1. Macdonald RL, Pluta RM, Zhang JH. Cerebral vasospasm after subarachnoid hemorrhage: the emerging revolution. Nat Clin Pract Neurol 2007; 3: 256-63.
2. Muroi C, Seule M, Mishima K, Keller E. Novel treatments for vasospasm after subarachnoid hemorrhage. Curr Opin Crit Care 2012; 18: 119-26.
3. Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A, Vajkoczy P, Wanke I, Bach D, Frey A, Marr A, Roux S, Kassell N. Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol 2011; 10: 618-25.
4. Vergouwen MD, Vermeulen M, Coert BA, Stroes ES, Roos YB. Microthrombosis after aneurysmal subarachnoid hemorrhage: an additional explanation for delayed cerebral ischemia. J Cereb Blood Flow Metab 2008; 28: 1761-70.
5. Friedrich B, Muller F, Feiler S, Scholler K, Plesnila N. Experimental subarachnoid hemorrhage causes early and long-lasting microarterial constriction and microthrombosis: an in-vivo microscopy study. J Cereb Blood Flow Metab 2011; 32: 447-55.
6. Pisapia JM, Xu X, Kelly J, Yeung J, Carrion G, Tong H, Meghan S, El-Falaky OM, Grady MS, Smith DH, Zaitsev S, Muzykantov VR, Stiefel MF, Stein SC. Microthrombosis after experimental subarachnoid hemorrhage: time course and effect of red blood cell-bound thrombin-activated pro-urokinase and clazosentan. Exp Neurol 2011; 233: 357-63.
7. Sabri M, Ai J, Lakovic K, D'Abbondanza J, Ilodigwe D, Macdonald RL. Mechanisms of microthrombi formation after experimental subarachnoid hemorrhage. Neuroscience 2012; 224: 26-37.
8. Muroi C, Hugelshofer M, Seule M, Tastan I, Fujioka M, Mishima K, Keller E. Correlation between systemic inflammatory parameter, occurrence of delayed neurological deficits and outcome after aneurysmal subarachnoid hemorrhage. Neurosurgery 2013; 72: 367-75.
9. Vergouwen MD, Bakhtiari K, van Geloven N, Vermeulen M, Roos YB, Meijers JC. Reduced ADAMTS13 activity in delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. J Cereb Blood Flow Metab 2009; 29: 1734-41.
10. Chaichana KL, Pradilla G, Huang J, Tamargo RJ. Role of inflammation (leukocyte-endothelial cell interactions) in vasospasm after subarachnoid hemorrhage. World Neurosurg 2010; 73: 22-41.
11. Sarrafzadeh A, Schlenk F, Gericke C, Vajkoczy P. Relevance of cerebral interleukin-6 after aneurysmal subarachnoid hemorrhage. Neurocrit Care 2010; 13: 339-46.
12. Zhu XD, Chen JS, Zhou F, Liu QC, Chen G, Zhang JM. Relationship between plasma high mobility group box-1 protein levels and clinical outcomes of aneurysmal subarachnoid hemorrhage. J Neuroinflammation 2012; 9: 194.
13. Sabri M, Ai J, Macdonald RL. Dissociation of vasospasm and secondary effects of experimental subarachnoid hemorrhage by clazosentan. Stroke 2011; 42: 1454-60.
14. Bernardo A, Ball C, Nolasco L, Moake JF, Dong JF. Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers under flow. Blood 2004; 104: 100-6.
15. Chauhan AK, Kisucka J, Brill A, Walsh MT, Scheiflinger F, Wagner DD. ADAMTS13: a new link between thrombosis and inflammation. J Exp Med 2008; 205: 2065-74.
16. Fujioka M, Hayakawa K, Mishima K, Kunizawa A, Irie K, Higuchi S, Nakano T, Muroi C, Fukushima H, Sugimoto M, Banno F, Kokame K, Miyata T, Fujiwara M, Okuchi K, Nishio K. ADAMTS13 gene deletion aggravates ischemic brain damage: a possible neuroprotective role of ADAMTS13 by ameliorating postischemic hypoperfusion. Blood 2010; 115: 1650-3.
17. Fujioka M, Nakano T, Hayakawa K, Irie K, Akitake Y, Sakamoto Y, Mishima K, Muroi C, Yonekawa Y, Banno F, Kokame K, Miyata T, Nishio K, Okuchi K, Iwasaki K, Fujiwara M, Siesjo BK. ADAMTS13 gene deletion enhances plasma high-mobility group box1 elevation and neuroinflammation in brain ischemia-reperfusion injury. Neurol Sci 2012; 33: 1107-15.
18. Khan MM, Motto DG, Lentz SR, Chauhan AK. ADAMTS13 reduces VWF-mediated acute inflammation following focal cerebral ischemia in mice. J Thromb Haemost 2012; 10: 1665-71.
19. Zhao BQ, Chauhan AK, Canault M, Patten IS, Yang JJ, Dockal M, Scheiflinger F, Wagner DD. von Willebrand factor-cleaving protease ADAMTS13 reduces ischemic brain injury in experimental stroke. Blood 2009; 114: 3329-34.
20. Macleod MR, Fisher M, O'Collins V, Sena ES, Dirnagl U, Bath PM, Buchan A, van der Worp HB, Traystman R, Minematsu K, Donnan GA, Howells DW. Good laboratory practice: preventing introduction of bias at the bench. Stroke 2009; 40: e50-2.
21. Garcia JH, Wagner S, Liu KF, Hu XJ. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation. Stroke 1995; 26: 627-34 discussion 35.
22. Bouet V, Freret T, Toutain J, Divoux D, Boulouard M, Schumann-Bard P. Sensorimotor and cognitive deficits after transient middle cerebral artery occlusion in the mouse. Exp Neurol 2007; 203: 555-67.
23. Sugawara T, Ayer R, Jadhav V, Zhang JH. A new grading system evaluating bleeding scale in filament perforation subarachnoid hemorrhage rat model. J Neurosci Methods 2008; 167: 327-34.
24. Qiu J, Nishimura M, Wang Y, Sims JR, Qiu S, Savitz SI, Salomone S, Moskowitz MA. Early release of HMGB-1 from neurons after the onset of brain ischemia. J Cereb Blood Flow Metab 2008; 28: 927-38.
25. Schmued LC, Stowers CC, Scallet AC, Xu L. Fluoro-Jade C results in ultra high resolution and contrast labeling of degenerating neurons. Brain Res 2005; 1035: 24-31.
26. Furlan M, Robles R, Morselli B, Sandoz P, Lammle B. Recovery and half-life of von Willebrand factor-cleaving protease after plasma therapy in patients with thrombotic thrombocytopenic purpura. Thromb Haemost 1999; 81: 8-13.
27. Sadler JE. von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura. Blood 2008; 112: 11-18.
28. Dorhout MS, van den Bergh WM, Algra A, Rinkel GJ. Antiplatelet therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 2007; CD006184.